Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Other Long Term Assets : ¥1,666 Mil (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Other Long Term Assets?

Shenzhenlubris Pharmaceuticals Co's other long-term assets for the quarter that ended in Mar. 2025 was ¥1,666 Mil.

Shenzhenlubris Pharmaceuticals Co's quarterly other long-term assets increased from Sep. 2024 (¥2,164 Mil) to Dec. 2024 (¥2,185 Mil) but then stayed the same from Dec. 2024 (¥2,185 Mil) to Mar. 2025 (¥1,666 Mil).

Shenzhenlubris Pharmaceuticals Co's annual other long-term assets increased from Dec. 2022 (¥1,293 Mil) to Dec. 2023 (¥1,999 Mil) and increased from Dec. 2023 (¥1,999 Mil) to Dec. 2024 (¥2,185 Mil).

Shenzhenlubris Pharmaceuticals Co Other Long Term Assets Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Other Long Term Assets Chart

Shenzhenlubris Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1,210.26

1,104.17

1,292.89

1,999.33

2,185.29

Shenzhenlubris Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															1,997.04	2,121.03	2,163.76	2,185.29	1,666.05

Shenzhenlubris Pharmaceuticals Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Shenzhenlubris Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6009 Shennan Road, 37th Floor, Main Building, Chegongmiao Lvjing Plaza, Futian District, Guangdong, Shenzhen, CHN, 518040

Website

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.

Executives

Yan Jie	Directors, executives
Yang Jian Feng	Secretary, Director
Zhao Song Ping	Executives
Liu Jun	Executives
Li Ai Zhen	Supervisors
Chen Ping	Executives
Ye Cheng Hai	Director
Lu Feng	Executives, directors
Chen Qiong Xing	Supervisors
Li Ying Hui	Supervisors
Pan Ling Man	Independent director
Zhang Zhong Xing	Executives

Shenzhenlubris Pharmaceuticals Co Headlines

No Headlines